by Ket Patel | Nov 11, 2012 | Slider Content
More than two-thirds of patients with medically refractory chronic cluster headache responded to on-demand, self-administered sphenopalatine ganglion stimulation with acute pain relief, less frequent attacks, or both. The prophylactic effect – a reduction in cluster...
by Ket Patel | Oct 29, 2012 | Slider Content
Occipital nerve blocks are an effective, safe, and well-tolerated therapy in patients with exacerbation of chronic or episodic cluster headache, according to two observational studies presented at the European Headache and Migraine Trust International Congress....
by Ket Patel | Oct 9, 2012 | Slider Content
Twenty-five percent of chronic migraine patients experience at least a 75% reduction in headache days per month after 6 months of treatment with onabotulinumtoxinA, according to a new analysis of data from the landmark PREEMPT trials. “That’s what I tell my...
by Ket Patel | Oct 9, 2012 | Uncategorized
Brief low-temperature radiofrequency rhizolysis of the C-1 spinal nerve and C-2 and C-3 dorsal root ganglia was safe and effective for occipital neuralgia with migraine in a retrospective series of 10 patients. “The pain reduction lasted for an average of 5½...
by Ket Patel | Oct 1, 2012 | Slider Content
Depression in patients with episodic migraine is an independent risk factor for transformation of their headache pattern into far more burdensome chronic migraine, according to data from the landmark American Migraine Prevalence and Prevention study. “The study...
